Navigation Links
IDM Pharma Reports 2008 Financial Results
Date:3/31/2009

TEMENTS OF OPERATIONS (unaudited) Quarter Ended Twelve Months Ended December 31, December 31, 2008 2007 2008 2007 Revenues: Related party revenue $- $5,252,000 $2,401,000 $14,246,000 Research grants and contract revenue (44,000) - 400,000 55,000 License fees, milestones and other revenues 334,000 299,000 346,000 329,000 Total revenues 290,000 5,551,000 3,147,000 14,630,000 Costs and expenses: Research and development 962,000 5,212,000 11,161,000 22,339,000 Selling and marketing 654,000 576,000 1,099,000 1,024,000 General and administrative 2,394,000 2,319,000 8,987,000 11,535,000 Restructuring (260,000) 1,092,000 3,472,000 1,092,000 Contract settlement income from related party - - (5,652,000) - Total costs and expenses 3,750,000 9,199,000 19,067,000 35,990,000 Loss from operations (3,460,000) (3,648,000) (15,920,000) (21,360,000) Interest income 98,000 360,000 722,000 1,118,000 Interest expense related to warrants 1,566,000 1,053,000 (3,072,000) 3,878,000 Other expenses, net 4,000 23,000 4,000 - Foreign exchange gain (loss) 86,000 (381,000) (95,000) (1,680,000) Loss before income tax (1,706,000) (2,593,000) (18,361,000) (18,044,000) Income tax expense (151,000) (89,000) (245,000) (306,
'/>"/>
SOURCE IDM Pharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Endo Pharmaceuticals Appoints Dr. Nancy Hutson to Board of Directors
2. The MedZilla Report: Febraury 2009 Employment Outlook for Biotech/Pharma/Health
3. Recent Graduates Finding BioTech & Pharmaceutical Jobs Easier Than Ever With The Launch of CampusRXBio
4. VIA Pharmaceuticals Complies With NASDAQ Rules
5. Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2008 Financial Results
6. Anadys Pharmaceuticals to Present at Future Leaders in the Biotech Industry
7. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at BioCentury Publications Inc. Future Leaders in the Biotech Industry Conference in New York on April 2, 2009
8. WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results
9. Trubion Pharmaceuticals, Inc. Announces Initiation of Phase 1 Study of SBI-087 for the Treatment of Systemic Lupus Erythematosus (SLE)
10. Isis Pharmaceuticals to Present at the 4th Annual Citi Biotech Day
11. ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... Research and Markets ... of the "Oxidative Stress Assay Market ... (Indirect, Enzyme-based, Reactive Oxygen Species (ROS)-based), Technology ... Global Forecast to 2020" report to ... , The global oxidative stress ...
(Date:6/1/2015)... 2015 GenomeDx Biosciences today announced ... successfully classified various subtypes of bladder cancer ... biomarkers, including one type associated with resistance ... signature has potential as a tool to ... patients with muscle-invasive bladder cancers (MIBC). The ...
(Date:6/1/2015)... 2015  Novartis is highlighting data from an ... investigational chimeric antigen receptor (CAR) T cell therapy, ... specific types of hard-to-treat non-Hodgkin lymphoma. Findings from ... Pennsylvania,s Perelman School of Medicine (Penn) in adults ... lymphoma (DLBCL) and follicular lymphoma (FL) found an ...
(Date:6/1/2015)... IL (PRWEB) June 01, 2015 ... developing and manufacturing of chiral stationary phases (CSPs) ... options for its current and presenting solutions for ... to its portfolio. This valuable addition to its ... and effective advantage that can tackle projects for ...
Breaking Biology Technology:Oxidative Stress Assay Market 2015 - Global Forecast to 2020 2GenomeDx's Decipher Platform Validates Genomic Signature that may Predict Resistance to Chemotherapy in Bladder Cancer Patients in Study Presented at ASCO 2015 Annual Meeting 2GenomeDx's Decipher Platform Validates Genomic Signature that may Predict Resistance to Chemotherapy in Bladder Cancer Patients in Study Presented at ASCO 2015 Annual Meeting 3GenomeDx's Decipher Platform Validates Genomic Signature that may Predict Resistance to Chemotherapy in Bladder Cancer Patients in Study Presented at ASCO 2015 Annual Meeting 4Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 2Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 3Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 4Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 5Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 6Regis Technologies Offers Chiral Chromatography Service 2Regis Technologies Offers Chiral Chromatography Service 3
... In past columns, I have written about the important ... pharmaceutical industry around the world. Their rise and growth ... drugs. , ,With 45 million Americans not having any ... and the doors to cheaper medicines from Canada being ...
... people in a significant way (like finding them a job ... appreciate little acts of kindness (like making them feel good ... these details may seem trivial to you, they are important ... Pay attention to how you interact with others because you ...
... to sample high-energy neutrino particles from deep space, are ... ice. Photo courtesy of Daan Hubert/UW-Madison. Madison, ... international team of scientists, engineers and technicians has set ... neutrino telescope at the South Pole. , ,The successful ...
Cached Biology Technology:Pharmas will be forced into generic-drug strategy 2Pharmas will be forced into generic-drug strategy 3Little things can be big in networking 2Little things can be big in networking 3First pieces of Antarctic deep-space particle detector are in place 2First pieces of Antarctic deep-space particle detector are in place 3First pieces of Antarctic deep-space particle detector are in place 4First pieces of Antarctic deep-space particle detector are in place 5
(Date:5/14/2015)... 14, 2015 Research and Markets ( ... "Fingerprint Sensors Market in Smart Mobile Devices " ... that 2014 was a watershed year for fingerprint sensors ... ,Apple Pay,. Apple gave fingerprint sensors a raison d,etre ... Fingerprint sensors are a must-have feature in flagship smartphones. ...
(Date:5/10/2015)... , May 11, 2015 Fingerprint Cards ... FPC1025 and FPC1155 from the distributor World Peace Industrial Group ... distributors in Asia . Deliveries are planned ... be used by smartphone manufacturers in China ... the communicated revenue guidance of + 1 000 MSEK for 2015. ...
(Date:4/27/2015)... , April 27, 2015  For more than ... trade show has been the premier worldwide event for ... 2015 is a must-attend event for any local, national, ... into the emerging commercial markets and current applications of ... innovations of this projected $48 billion industry, and how ...
Breaking Biology News(10 mins):Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 235 Million 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5
... protein deficiency through gene therapy can correct motor function, restore ... a model for the lethal childhood disorder spinal muscular atrophy, ... child,s motor neurons nerve cells that send signals from ... what is called survival motor neuron protein, or SMN. This ...
... Cancer researchers have high hopes for a new therapy for ... is a new drug being assessed in a Phase I ... collaboration with the Clinical Division of the Translational Genomics Research ... under way through a partnership between the Virginia G. Piper ...
... University of Pennsylvania,s Laboratory for Research on the ... agreement with specialty chemical producer Rhodia and the ... an international, public-private research collaboration in soft condensed ... industry brings together a diverse team of world-class ...
Cached Biology News:Study: Gene therapy reverses effects of lethal childhood muscle disorder in mice 2Study: Gene therapy reverses effects of lethal childhood muscle disorder in mice 3Study: Gene therapy reverses effects of lethal childhood muscle disorder in mice 4New cancer treatment gives hope to lymphoma and leukemia patients 2Penn joins international collaboration in government and academics to research 'soft matter' 2
... XS uniquely combines a single-channel sample processing ... 8-channel bulk reagent dispenser all in one ... using disposable pipette tips, the Precision XS ... dispenser is available for transferring larger volumes. ...
... ATP-Gamma-S binds to ATP-binding proteins. To ... FL fluorophore was linked through the ... its potential use for binding studies ... an important new substrate for Fhit ...
... of discovery races ever faster, you need a ... track. So our constant focus is on providing ... Thats why our Biomek 3000 Laboratory Automation Workstation ... as it is flexible. By integrating all aspects ...
... standard microarray image analysis software because of ... tools, visualizations, automation capabilities, performance and ease ... every GenePix scanner, and it also imports ... types of arrays. A wide range of ...
Biology Products: